Ketan Tamirisa

Private equity’s growing influence on American health care has outpaced regulatory oversight. Stronger policies are necessary to safeguard patients, providers, and care delivery.

This commentary examines pressures driving cardiology consolidation, the risks of private equity, and strategies to sustain independent practice while ensuring patient-centered, cost-effective cardiovascular care.